IHS Chemical Week

People & Business :: Companies

Bayer Sues Teva for Patent Infringement

8:29 AM MDT | July 6, 2009 | Natasha Alperowicz

Bayer Schering Pharma AG,  Bayer HealthCare Pharmaceuticals Inc., and Schering Corporation have jointly filed a patent infringement lawsuit in the U.S. Federal Court in the District of Delaware against Teva Pharmaceuticals USA and Teva Pharmaceutical Industries Ltd. The lawsuit concerns Teva's application to the FDA for approval to market a generic form of Levitra, Bayer Schering Pharma's therapy for the treatment of erectile dysfunction, prior to patent expiration. Bayer says the patent at issue is Bayer Schering Pharma's U.S. Patent No. 6,362,178...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa